Notícias

Mizuho cuts Circle to underperform, citing rising stablecoin competition and risks from Open USD.

Strategy's Bitcoin sale and stalled U.S. crypto legislation add pressure as investor demand weakens.

The S&P 500 is hovering around all-time highs, but some investors worry a sell-off could be imminent.

Boeing investors will have a lot of news to digest this week. They should focus on supply chain updates.

Oracle and Bloom Energy shares fell after New Mexico rejected, for a second time, a permit needed for a pipeline serving Oracle's Project Jupiter AI data center.

Michael Saylor-led Strategy (Nasdaq: MSTR), formerly MicroStrategy, repeated its playbook from last week as it again sold the company's common shares to boost its cash reserve while adding no Bitcoin (BTC) to its balance sheet. The company disclosed in its filing with the Securities and ...

U.S. regulators walked back its findings about contaminated lettuce, saying that the Taylor Farms sample initially reported as positive for cyclospora was actually a false positive.

IBM just suffered its worst single-week collapse since 1968, yet one prominent analyst refuses to budge from a price target that implies more than 60% upside. What he sees in the wreckage that the sellers are missing could reshape the entire enterprise AI trade.

Procter & Gamble (PG) investors are bracing for the company's fiscal Q4 organic sales to fall short

Arbutus Biopharma and Genevant Sciences have filed multiple patent infringement lawsuits against Pfizer and BioNTech over their mRNA-LNP COVID-19 vaccines. The new cases extend beyond the existing U.S. litigation into several international jurisdictions. The lawsuits seek monetary damages and potential injunctions on vaccine products, raising legal and operational risks for Pfizer. Pfizer, listed as NYSE:PFE, is facing an expanded legal challenge as Arbutus Biopharma and Genevant Sciences...

According to a CNBC report, Morgan Stanley analyst Joseph Moore said in a note on Monday the firm's preferred AI investments remain compute names.

ARM’s stock saw the largest price target cut, though UBS reiterated its 'Buy' rating and retained 'Neutral' ratings for both Qualcomm and KLA.

These ETFs Face the Biggest Netflix Risk After Earnings Selloff

Monster Beverage (NASDAQ:MNST) was downgraded to Hold from Buy by Deutsche Bank, with analysts arguing that the energy drink maker’s recent share price rally has left limited room for further gains despite the company’s continued operational strength. The brokerage also increased its price target to $98 but noted that the revised target represents only around 1% upside from current levels.

Strategy stock rose early Monday after the bitcoin juggernaut disclosed that it raised $263 million by selling common stock last week.

The United States has been quietly draining its emergency oil stockpile at a record pace, and one analyst says the moment it runs dry could trigger a price shock the market is not prepared for.

Time for IBM to explore a different future?

Investing.com -- Monster Beverage was downgraded to Hold from Buy by analysts at Deutsche Bank, who said the energy drink maker's recent share outperformance has left its valuation reflecting expectations that are difficult to exceed despite the company's strong operational momentum.

AMS and its local partner MaxMass have provided mining services at the open-pit Iduapriem mine since 2018.

CLB struggles with ongoing headwinds from lower completion activity, operational disruptions, inflationary costs, weaker margins and projected earnings decline in 2026.

(Bloomberg) -- Hedge funds pulled back from US tech stocks at a record pace over the past two months, according to Goldman Sachs Group Inc.’s Prime Services desk.Most Read from BloombergUS Strikes Iran in Escalating Campaign After Troops KilledThousands of Trucks Haul Iraq’s Oil Through Syria in Sign of Hormuz LegacyUS Strikes Iran to ‘Punish’ It for Attack That Killed 2 TroopsTrump Silent So Far on Iran Plans as US Death Toll Hits 17FCC Near Rulings Against Disney Over ‘The View,’ TV LicensesTh

A new class action lawsuit alleges a coolant leak defect in certain Chevrolet, GMC, and Buick vehicles produced by General Motors (NYSE:GM). Plaintiffs claim GM knew about an engine issue tied to coolant leaks and did not adequately warn customers or fix the problem. The suit alleges violations of warranty and consumer protection laws and seeks relief on behalf of affected vehicle owners. General Motors remains a major global automaker with a portfolio that spans internal combustion...

Mira Murati's startup just launched its first open-weight model with a 1-gigawatt Nvidia partnership behind it, and the timing puts serious pressure on closed-source labs riding high on premium pricing.

Investing.com -- Goldman Sachs told clients in a note on Monday that a broad selloff in European software stocks, driven by the rapid rise of agentic AI, is creating opportunities as the market reassesses incumbent value propositions.

H.C. Wainwright and Berenberg became the latest firms to downgrade the stock following Eli Lilly's acquisition agreement.

(Bloomberg) -- Lawyers for President Donald Trump and his sprawling business interests are heading to court this week in Florida for high-stakes hearings that follow a pair of major setbacks in their wave of multibillion-dollar lawsuits.Most Read from BloombergUS Strikes Iran in Escalating Campaign After Troops KilledThousands of Trucks Haul Iraq’s Oil Through Syria in Sign of Hormuz LegacyUS Strikes Iran to ‘Punish’ It for Attack That Killed 2 TroopsTrump Silent So Far on Iran Plans as US Death

The Pittsburgh-based company lowered its full-year alumina expectations as it looks to return its Pinjarra refinery to normal operations.

The unwind in artificial intelligence and momentum stocks is entering its maturing stage and should not trigger prolonged market weakness, according to JP Morgan. The bank's equity strategists, led by Mislav Matejka, noted a challenging few weeks for AI-linked groups, with Korea's market down...

Freedom Capital raised its rating from ‘Hold’ to ‘Buy’ and lifted its price target to $200 from $159, according to The Fly.

Investing.com -- Morgan Stanley told investors in a note Monday that it believes the recent selloff in U.S. memory stocks presents a buying opportunity, arguing that data center memory shortages continue to intensify even as mixed signals emerge elsewhere in the market.